A FAMILY CASE OF FABRY DISEASE


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

The paper describes a family case of rare lysosomal storage disease. The diagnosis of Fabry disease (FD) is based on its clinical symptoms, enzyme diagnosis, and molecular genetic diagnosis. The paper also analyzes the phenotypic spectrum and discusses early diagnosis and enzyme replacement therapy in children with FD in the Republic of Sakha (Yakutia). The diagnosis of the orphan disease represents a challenge due to its nonspecific symptoms. Screening high-risk individuals is recommended for the early detection of FD.

Full Text

Restricted Access

About the authors

R. Ivanova

Center of Medical Genetics, Republican Hospital One - National Center of Medicine, Y

Email: ya.irr84@yandex.ru
Yakutsk

A. Sukhomyasova

Center of Medical Genetics, Republican Hospital One - National Center of Medicine, Y; M.K. Ammosov North-Eastern Federal University

Email: ya.irr84@yandex.ru
Yakutsk

E. Gurlnova

Center of Medical Genetics, Republican Hospital One - National Center of Medicine, Y

Email: ya.irr84@yandex.ru
Yakutsk

F. Vasilyev

M.K. Ammosov North-Eastern Federal University

Email: ya.irr84@yandex.ru
Yakutsk

P. Guryeva

M.K. Ammosov North-Eastern Federal University

Email: ya.irr84@yandex.ru
Yakutsk

A. Gorokhova

Center of Medical Genetics, Republican Hospital One - National Center of Medicine, Y

Email: ya.irr84@yandex.ru
Yakutsk

N. Makslmova

M.K. Ammosov North-Eastern Federal University

Email: ya.irr84@yandex.ru
Yakutsk

References

  1. Schiffmann R., Ries M. Fabry Disease: A Disorder of Childhood Onset // Pediatr. Neurol. - 2016; 64: 10-20.
  2. Mehta A., Ricci R., Widmer U. et al. Fabry disease defined: baseline clinical manifestations of 366 patients in the Fabry Outcome Survey // Eur. J. Clin. Invest. - 2004; 34: 236-42.
  3. Tse K., Chan K., Tin V. et al. Clinical features and genetic analysis of a Chinese kindred with Fabry's disease // Nephrol. Dial Transplant. - 2003; 18 (1): 182-6.
  4. Owada M., Kitigawa T. Lysosomal storage diseases // Nippon Rinsho. -2001; 8: 317-27.
  5. Meikle P., Hopwood J., Clague A. et al. Prevalence of lysosomal storage disorders // JAMA. - 1999; 281: 249-54.
  6. Poorthuis B., Wevers R., Kleijer W. et al. The frequency of lysosomal storage diseases in The Netherlands // Hum. Genet. - 1999; 105: 151-6.
  7. Новиков П.В., Асанов А.Ю., Копишинская С.В. и др. Федеральные клинические рекомендации по диагностике и лечению болезни Фабри / М., 2013; 26 с.
  8. MacDermot K., Holmes A., Miners A. Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 60 obligate carrier females // J. Med. Genet. - 2001; 38 (11): 769-75.
  9. Wang R., Lelis A., Mirocha J. et al. Heterozygous Fabry women are not just carriers, but have a significant burden of disease and impaired quality of life // Genet. Med. - 2007; 9 (1): 34-45.
  10. Байер Е.М., Карпова Е.А., Удалова О.В. и др. Биохимическое исследование необычных случаев болезни Фабри / М., 1996; 494-500.
  11. Краснопольская К.Д. Наследственные болезни обмена веществ. Справочное пособие для врачей / М.: Фохат: 2005; 364 с.
  12. Михайлова С.В., Захарова Е.Ю., Петрухин А.С. Нейрометаболические заболевания у детей и подростков: диагностика и подходы к лечению. Практическое руководство / М.: Литера, 2011; 352 с.
  13. Bishop D., Kornreich R., Desnick R. Structural organization of the human alpha-galactosidase A gene: further evidence for the absence of a 3’ untranslated region // Proc. Natl. Acad. Sci. USA. - 1988; 85: 3903-7.
  14. Garman S., Garboczi D. The molecular defect leading to Fabry disease: structure of human alpha-galactosidase // J. Mol. Biol. - 2004; 337: 319-35.
  15. The Human Gene Mutation Database at the Institute of Medical Genetics in Cardiff [Электронный ресурс]. - Режим доступа: http://www.hgmd.cf.ac.uk/ac/ index.php. - 03.02.2017.
  16. Germain D., Giugliani R., Hughes D. et al. Safety and pharmacodynamic effects of a pharmacological chaperone on а-galactosidase A activity and globotriaosylceramide clearance in Fabry disease: report from two phase 2 clinical studies // Orphanet. J. Rare Dis. - 2012; 7: 91.
  17. Aerts J., Groener J., Kuiper S. et al. Elevated globotriaosylsphingosine is a hallmark of Fabry disease // Proc. Natl. Acad. Sci. USA. - 2008; 105 (8): 2812-7.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2017 Russkiy Vrach Publishing House